LARUSSA, Tiziana
 Distribuzione geografica
Continente #
NA - Nord America 893
EU - Europa 614
AS - Asia 456
OC - Oceania 10
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 6
AF - Africa 3
Totale 1.990
Nazione #
US - Stati Uniti d'America 851
SG - Singapore 243
IT - Italia 225
DE - Germania 117
CN - Cina 104
GB - Regno Unito 90
FI - Finlandia 54
SE - Svezia 53
IR - Iran 38
CA - Canada 35
IN - India 33
NL - Olanda 23
TR - Turchia 11
TW - Taiwan 11
RU - Federazione Russa 10
AU - Australia 9
HK - Hong Kong 7
FR - Francia 6
RO - Romania 6
MX - Messico 5
BR - Brasile 4
EU - Europa 4
PL - Polonia 4
UA - Ucraina 4
AT - Austria 3
CL - Cile 3
ES - Italia 3
PH - Filippine 3
SK - Slovacchia (Repubblica Slovacca) 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BE - Belgio 2
CH - Svizzera 2
CU - Cuba 2
CZ - Repubblica Ceca 2
HU - Ungheria 2
SA - Arabia Saudita 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
DK - Danimarca 1
EE - Estonia 1
EG - Egitto 1
GR - Grecia 1
IL - Israele 1
IQ - Iraq 1
JP - Giappone 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PY - Paraguay 1
Totale 1.990
Città #
Chandler 152
Munich 98
Chicago 87
London 82
Singapore 80
Santa Clara 78
Lawrence 68
Princeton 68
Milan 66
Helsinki 46
Wilmington 41
Ashburn 32
Ottawa 30
Catanzaro 28
Des Moines 21
Redwood City 19
Mumbai 17
Mendicino 12
Shanghai 11
Beijing 10
Guangzhou 10
Praia A Mare 9
Collegeville 7
Pune 7
Rome 7
Tehran 7
Cittanova 6
Redmond 6
Boardman 5
Hanover 5
Hong Kong 5
Jyväskylä 5
Norwalk 5
Shenzhen 5
Clearwater 4
Horia 4
Istanbul 4
Selargius 4
Taipei 4
Bade District 3
Bari 3
Benevento 3
Bratislava 3
Jiaxing 3
Kahramanmaraş 3
Los Angeles 3
Miguel Hidalgo 3
Nanjing 3
Naples 3
Paris 3
Phoenix 3
Rende 3
The Dalles 3
Wuxi 3
Zabki 3
Ann Arbor 2
Bungarribee 2
Calumpit 2
Cape Town 2
Capurso 2
Castel Campagnano 2
Chelsea 2
Esslingen am Neckar 2
Frankfurt am Main 2
Fremont 2
Havana 2
Hefei 2
Leuven 2
Lyon 2
Miami 2
Montreal 2
New Taipei City 2
Palermo 2
Pasargad 2
Pécs 2
Riyadh 2
San Nicola Manfredi 2
Shenyang 2
Silea 2
St Petersburg 2
São Paulo 2
Toronto 2
Vienna 2
Wanchai 2
Xi'an 2
Zhengzhou 2
Acireale 1
Adelaide 1
Agnone 1
Antalya 1
Anyang 1
Auckland 1
Baoding 1
Benito Juárez 1
Boca Raton 1
Bologna 1
Bucharest 1
Buffalo 1
Burlington 1
Böblingen 1
Totale 1.279
Nome #
Adverse drug reactions during biologic therapy in inflammatory disease: real life data from the pharmacovigilance project in the Calabria region 202
Dietary polyphenolsand non-alcoholic fatty liver disease 69
Efficacy of Mediterranean diet and antioxidants in overweight patients with non-alcoholic fatty liver disease. 52
Barriers And Facilitators In Conducting Clinical Trials In Inflammatory Bowel Disease: A Monocentric Italian Survey. 52
The role of gluten-free diet in nonalcoholic fatty liver disease development 50
Long-term, Real-life, Observational Study in Treating Outpatient Ulcerative Colitis with Golimumab 48
COVID-19 and Inflammatory Bowel Disease: Patient Knowledge and Perceptions in a Single Center Survey 47
Gut Microbiota and Liver Interaction through Immune System Cross-Talk: A Comprehensive Review at the Time of the SARS-CoV-2 Pandemic. 42
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy 41
Anxiety and Gastrointestinal Symptoms Related to COVID-19 during Italian Lockdown 39
Real-life burden of adverse reactions to biological therapy in inflammatory bowel disease: a single-centre prospective case series. 39
Effectiveness and safety of adalimumab to treat outpatient ulcerative colitis: A real-life multicenter, observational study in primary inflammatory bowel disease centers 38
Enhanced expression of indoleamine 2,3-dioxygenase (IDO) in Helicobacter pylori-infected human gastric mucosa modulates TH1/TH2 patway and interleukin (IL)-17 production. 38
A Framework for Patient Data Management and Analysis in Randomised Clinical Trials 38
Oleuropein Decreases Cyclooxygenase-2 and Interleukin-17 Expression and Attenuates Inflammatory Damage in Colonic Samples from Ulcerative Colitis Patients 35
SARS-CoV-2 Spread Dynamics in Italy: The Calabria Experience 35
Enhanced expression of indole amine 2,3-dioxygenase (IDO) in Helicobacter pylori-infected human gastric muciosa downregulates interleukin (IL)-17 and upregulates IL-4 production. 34
Effectiveness and Safety of Golimumab in Treating Outpatient Ulcerative Colitis: A Real-Life Prospective, Multicentre, Observational Study in Primary Inflammatory Bowel Diseases Centers 33
Effect of selective cyclooxygenase (Cox)-2 Inhibition and proton pump inhibitors (PPI) therapy on TH1 immune response in human gastric mucosa 32
Gut microbiota and non-alcoholic fatty liver disease 32
Bone mineralization in celiac disease 31
Very low vitamin D level is an independent risk factor for bone demineralization in IBD patients 30
Diminished circulating concentration of interleukin-35 in Helicobacter pylori-infected patients with peptic ulcer: Its association with FOXP3 gene polymorphism, bacterial virulence factor CagA, and gender of patients 30
Decreased circulating interleukin-33 concentration in Helicobacter pylori-infected patients with peptic ulcer: Evaluation of its association with a cytokine gene polymorphism, gender of patients and bacterial virulence factor CagA 30
Helicobacter pylori and T Helper Cells: Mechanisms of Immune Escape and Tolerance 29
Self-Prescribed Dietary Restrictions are Common in Inflammatory Bowel Disease Patients and Are Associated with Low Bone Mineralization 29
Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study 28
Vedolizumab is effective and safe in real-life treatment of inflammatory bowel diseases outpatients: A multicenter, observational study in primary inflammatory bowel disease centers 28
Downregulation of Interleukin- (IL-) 17 through Enhanced Indoleamine 2,3-Dioxygenase (IDO) Induction by Curcumin: A Potential Mechanism of Tolerance towards Helicobacter pylori 27
Enhanced activation of cyclooxygenase-2 down-regulates Th1 signaling pathway in Helicobacter pylori-infected human gastric mucosa 26
Mediterranean diet and probiotics supplementation to treat non-alcoholic fatty liver disease 26
Long-term real-life efficacy and safety of infliximab and adalimumab in the treatment of inflammatory bowel diseases outpatients 25
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy 25
Living with inflammatory bowel diseases: patients’ perceptions and unmet needs from a single-center Italian survey 25
Reduced bone mineral density is frequent in treated adult coeliac disease not with standing complete normalization of duodenal lesions. 25
Crohn disease: Identification, diagnosis, and clinical management. 25
Oleuropein decreases interleukin-17 and attenuates inflammatory damage in colonic mucosa from ulcerative colitis patients 24
Potential role of fecal gluten immunogenic peptides to assess dietary compliance in celiac patients 24
Survey on alcohol consumption in a gastroenetrology outpatient center in southern Italy. 24
Normal Bone Mineral Density Associates with Duodenal Mucosa Healing in Adult Patients with Celiac Disease on a Gluten-Free Diet 23
SURVEY ON ALCOHOL CONSUMPTION IN A GASTROENTEROLOGY OUTPATIENT CENTER IN SOUTHERN ITALY 23
Effect of selective cyclooxygenase (COX)-2 inhibition and proton pump inhibitors (PPI) therapy on TH1 immune response in human gastric mucosa 23
The protective effects of resveratrol on ulcerative colitis via changing the profile of Nrf2 and IL-1β protein 23
Safety profile of intravenous iron in inflammatory bowel disease: an up-to-date overview 22
Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to standard pharmeceutical treatment: a double-blind, randomized, placebo-controlled study 21
Gut microbiota in inflammatory bowel disease: a target for therapy not to be missed. 21
Enhanced Expression of Indoleamine 2,3-Dioxygenase (IDO) in Helicobacter pylori-Infected Human Gastric Mucosa Modulates TH1/Th2 Pathway and Interleukin (IL)-17 Production. 20
T cell subsets play an important role in the determination of the clinical outcome of Helicobacter pylori infection 19
The Reality of Patient-Reported Outcomes of Health-Related Quality of Life in an Italian Cohort of Patients with Inflammatory Bowel Disease: Results from a Cross-Sectional Study 19
Replacement of Adalimumab Originator to Adalimumab Biosimilar for a Non-Medical Reason in Patients with Inflammatory Bowel Disease: A Real-life Comparison of Adalimumab Biosimilars Currently Available in Italy 18
No evidence of circulating autoantibodies against osteoprotegerin in treated celiac patients with low bone mineral density. 18
Short-term Therapy with Celecoxib and Lansoprazole Modulates Th1/Th2 Immune Response in Human Gastric Mucosa 18
High Exposure, Spontaneous Clearance, and Low Incidence of Active Helicobacter pylori Infection: The Sorbo San Basile Study 18
Liver Cirrhosis Complications Management At The Emergency Department 17
Lactobacillus paracasei F19 versus placebo for the prevention of proton pump inhibitor-induced bowel symptoms: a randomized clinical trial 17
Infliximab biosimilar CT-P13 is effective and safe in treating inflammatory bowel diseases: a real-life multicenter, observational study in Italian primary inflammatory bowel disease centers 16
Nutrigenomics and Nutrigenetics in Metabolic- (Dysfunction) Associated Fatty Liver Disease: Novel Insights and Future Perspectives 16
Enhanced expression of indoleamine 2,3-dioxygenase in Helicobacter pylori-infected human gastric mucosa modulates Th1/Th2 pathway and interleukin 17 production 15
Epidemiology of Helicobacter pylori infection: the Sorbo San Basile study. 15
Use of Complementary and Alternative Medicine by Patients with Irritable Bowel Syndrome According to the Roma IV Criteria: A Single-Center Italian Survey 15
OLEUROPEIN EXERTS ANTIOXIDANT ACTIVITY AND REDUCES THE EXPRESSION OF COX-2 AND PROINFLAMMATORY CYTOKINES IN CACO-2 CELLS AND COLONIC MUCOSA FROM ULCERATIVE COLITIS PATIENTS 15
Liver steatosis in celiac disease: the open door 14
Increased Indoleamine 2, 3-Dioxygenase expression modulates Th1/Th17/Th22 and Treg pathway in humans with Helicobacter Pylori-Infected gastric mucosa 14
Enhanced expression of indoleamine 2,3-dioxygenase in Helicobacter pylori-infected human gastric mucosa modulates Th1/Th2 pathway and interleukin 17 production 13
High prevalence of polymorphism and low activity of thiopurine methyltransferase in patients with inflammatory bowel disease. 13
Vitamin D down-regulates the expression of some Th17 cell-related cytokines, key inflammatory chemokines, and chemokine receptors in experimental autoimmune encephalomyelitis 13
Toll-like receptor 2: An important immunomodulatory molecule during Helicobacter pylori infection 13
Refractory ulcerative colitis complicated by cytomegalovirus infection successfully treated with valganciclovir 13
Multifaceted pathogenesis of liver steatosis in inflammatory bowel disease: A systematic review 13
No evidence of circulating autoantibodies against osteoprotegerin in patients with celiac disease 12
High prevalence of polymorphism and low activity of thiopurine methiltransferase in patients with inflammatory bowel disease. 11
Potential role of nutraceutical compounds in inflammatory bowel disease 11
Real-life efficacy and safety of Ustekinumab as second- or third-line therapy in Crohn's disease: results from a large Italian cohort study 11
Trends and characteristics associated with dietary triggers and psychological distress in patients with irritable bowel syndrome: a cross-sectional study 9
Olive Tree Biophenols in Inflammatory Bowel Disease: When Bitter is Better 9
From Pre- and Probiotics to Post-Biotics: A Narrative Review. 9
Beneficial effects of coffee in non-alcoholic fatty liver disease: a narrative review 7
Totale 2.104
Categoria #
all - tutte 25.997
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.997


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202077 0 0 0 0 0 0 0 0 0 0 46 31
2020/2021135 9 8 2 16 17 13 10 19 32 7 2 0
2021/2022258 8 7 14 49 17 4 10 48 22 26 37 16
2022/2023610 138 35 48 41 34 36 7 50 55 96 62 8
2023/2024290 69 20 25 16 10 75 6 15 27 2 9 16
2024/2025694 119 45 43 18 70 121 64 42 159 8 5 0
Totale 2.104